Navin Molecular (Navin Fluorine CDMO)
Is this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
Navin Molecular (Navin Fluorine CDMO) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Rare Disease
Metabolic
Quick Facts
HQ:India
Founded:2001
Employees:1,193
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Biologics Manufacturing
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Prefilled Syringe
Sterile Injectable
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Global
Regulatory Approvals
Drug Approval ANPLGW
FDA · #APR-0UKARBZP · 2019-11-01
Certifications
WHO GMP
World Health Organization
Cert #: CERT-M2ALA9CX
Issued: 2020-12-02
Expires: 2025-12-02
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-26FYGGOZ
Issued: 2020-07-19
Expires: 2025-09-14
Health Canada GMP
Health Canada
Cert #: CERT-LK3HJZ2F
Issued: 2020-12-19
Expires: 2025-05-06
Loading CDMO intelligence...
Key facts about Navin Molecular (Navin Fluorine CDMO)
- Navin Molecular (Navin Fluorine CDMO) is headquartered in India.
- Navin Molecular (Navin Fluorine CDMO) was founded in 2001.
- Navin Molecular (Navin Fluorine CDMO) has 1,193 employees.
- Navin Molecular (Navin Fluorine CDMO)'s capabilities include Biologics Drug Substance, Biologics Drug Product and Biologics Manufacturing.
Find CDMOs like Navin Molecular (Navin Fluorine CDMO)
Directory pages this company appears in, each with the full list of matching manufacturers.